Navigation Links
Pharmacopeia to Host First Quarter 2008 Financial Results Webcast and Conference Call
Date:4/23/2008

PRINCETON, N.J., April 23 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that the company plans to release its financial results for the first quarter ended March 31, 2008, after the close of market on Wednesday, May 7, 2008. The company will conduct a webcast and conference call at 5:00 p.m. EDT on the same day.

Dr. Joseph A. Mollica, Chairman of the Board and Acting Chief Executive Officer, Mr. Brian M. Posner, Executive Vice President and Chief Financial Officer, and Dr. Rene Belder, Senior Vice President, Clinical and Regulatory Affairs, will host the call. Forward-looking and other material information may be discussed on this conference call.

Date: May 7, 2008

Time: 5:00 p.m. EDT

Webcast: Accessible via the company's website at

http://www.pharmacopeia.com

US/Canadian participants: 877-681-3367

International participants: 719-325-4855

Confirmation code: 9717744

Name of conference: Pharmacopeia's First Quarter 2008 Financial Results

Conference Call

A replay of the conference call can be accessed by dialing toll-free (888) 203-1112 in the U.S., or (719) 457-0820 outside the U.S. The access code for the replay is 9717744. Replay of the webcast will also be accessible on Pharmacopeia's website on the Investors page at http://www.pharmacopeia.com. The replays will be available for two weeks.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2. Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference
3. Pharmacopeia Announces Management Team Changes
4. Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference
5. Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
6. Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference
7. Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
10. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
11. Genmab Announces 2007 First Half Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Physicists Sergei Filippov (MIPT and Russian Quantum Center ... Brno, Czech Republic, and the Institute of Physics ... preserve quantum entanglement of particles passing through an ... long distances. Details are provided in an article ... (see preprint). , Quantum entangled particles are ...
(Date:7/23/2014)... MD (PRWEB) July 23, 2014 ... an LC/MS amino acid analysis system developed jointly ... the UF-Amino Station can analyze 38 amino acids ... The UF-Amino Station achieves high-speed analysis utilizing a ... The LCMS-2020 provides accurate analytical results even under ...
(Date:7/23/2014)... 2014 StemGenex® , the leading ... US aimed at improving the lives of patients dealing ... for Parkinson’s disease. StemGenex believes that a commitment ... are paramount when providing care to patients with degenerative ... cell therapy accessible to the millions of individuals currently ...
(Date:7/23/2014)... 23, 2014 regulated information -- UCB today announced ... pipeline with positive topline results from the latest ... was designed to evaluate the efficacy and safety ... without titration) compared to placebo, as adjunctive treatment ... not fully controlled despite treatment with one or ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
... Mass., Oct. 10 Targanta,Therapeutics Corporation (Nasdaq: TARG ... of 5,750,000 shares of its common stock at a ... the shares are being offered by,Targanta. Targanta has granted ... an additional 862,500 shares of common stock at the ...
... Signalife has received,additional sales orders in excess of ... Lowell Harmison,s most recent cross-country sales,initiative. These purchase orders ... the company anticipates achieving break-even status,by the end of ... of 2008 first,quarter. About Signalife: Signalife, Inc. ...
... 10 DermTech International, Inc.,a biotechnology company ... of melanoma and other diseases, today appointed ... Board. Dr. Quackenbush is a,Professor of Biostatistics ... and Professor of Computational Biology and Bioinformatics,at ...
Cached Biology Technology:Targanta Therapeutics Announces Pricing of its Initial Public Offering 2Signalife Continues to Procure Purchase Orders, Revenues 2DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Company's Scientific Advisory Board 2
(Date:7/24/2014)... gut that has gone undetected by scientists for decades. ... State University has found that more than half the ... named crAssphage, which infects one of the most common ... of bacteria is thought to be connected with obesity, ... in Nature Communications ., Robert A. Edwards, a ...
(Date:7/23/2014)... or neglected early in life are at risk ... In a new study, scientists have found that ... has implications for children,s long-term development. Previous studies ... and genetics interacted with that child,s experiences in ... In the new study, researchers were able to ...
(Date:7/23/2014)... of Defense recently awarded the STEMPREP Project at ... support its goal of increasing the number of ... minority middle school students for the two-summer classroom ... school students with summer opportunities at research labs. ... Simmons School of Education and Human Development, boasts ...
Breaking Biology News(10 mins):Newly discovered gut virus lives in half the world's population 2Newly discovered gut virus lives in half the world's population 3Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3Department of Defense awards $2.6 million grant to SMU STEM program for minority students 2
... NY, June 27, 2011Sophisticated genetic tools and techniques for ... in bone marrow will drive the successful application of ... Examples of these cutting-edge methods are presented in a ... of Human Gene Therapy , a peer-reviewed journal ...
... A team of researchers from the National Institute ... and the University of Maryland has made nano-sized ... from paints, cleaners, pesticides and other productsthat offer ... low-power room-temperature operation and the ability to detect ...
... Most previous studies have indicated that people in cities have ... country. By using more complex methods of analysis than in ... that people,s carbon emissions are practically the same in the ... CO 2 emissions that cause climate change are dependent ...
Cached Biology News:The promise of stem cell-based gene therapy 2Nanowire-based sensors offer improved detection of volatile organic compounds 2City dwellers produce as much CO2 as countryside people do 2
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... to ThPok ( Abpromise for all tested ... conjugated to KLH derived from within residues 500 ... the amino acid sequence is proprietary) ... Entrez Gene ID: 51043 ...
Applications: Western blotting Stability: Room temperature, indefinitely ...
Rabbit polyclonal to SUR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide Entrez Gene ID: 6833 Swiss Protein ID: Q09428...
Biology Products: